Clinical Trials Directory

Trials / Completed

CompletedNCT01757678

HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography

HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography: NeXt sTeps

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
276 (actual)
Sponsor
HeartFlow, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine the diagnostic performance of FFRCT by coronary computed tomographic angiography (cCTA), as compared to cCTA alone, for non-invasive determination of the presence of a hemodynamically significant coronary lesion, using direct measurement of fractional flow reserve (FFR) during cardiac catheterization as a reference standard.

Detailed description

Recently, coronary Computed Tomography Angiography (cCTA) of 64-detector rows or greater has emerged as a novel non-invasive imaging modality that is capable of providing high-resolution images of coronary artery lesions (Budoff 2008; Miller 2008; Meijboom 2008). While cCTA demonstrates good diagnostic performance for detection and exclusion of anatomic coronary artery stenoses, numerous prior studies have revealed an unreliable relationship between detection of obstructive anatomic coronary artery stenoses by cCTA and hemodynamically (HD)-significant coronary artery disease (CAD), identified by myocardial perfusion SPECT or fractional flow reserve (FFR) (Di Carli 2007; Klauss 2007; Rispler 2007; van Werkhoven 2009). Individual subjects may have HD-significant CAD despite cCTA assessment demonstrating angiographically mild (\<50%) maximal stenosis (Schuijf 2006). These findings emphasize the need for additional measures beyond anatomic stenosis severity for the detection and exclusion of HD-significant CAD. Measurement of FFR during invasive cardiac catheterization represents the "gold standard" for assessment of the hemodynamic significance of coronary artery lesions (Kern 2010). Anatomic coronary artery stenosis assessment by quantitative coronary angiography (QCA) also correlates very poorly with FFR Melikian 2010). This was highlighted by the results of the FAME study in which FFR-guided coronary revascularization improved healthcare and economic outcomes compared to the conventional angiographically guided strategy (Pijls 2010; Tonino 2009; Tonino 2010). The major disadvantage of FFR is that it has to be measured invasively. HeartFlow, Inc. ('HeartFlow') has recently developed a non-invasive method to determine FFR which computes the hemodynamic significance of CAD (FFRCT) from subject-specific cCTA data using computational fluid dynamics under rest and simulated maximal coronary hyperemic conditions. Preliminary results in subjects suggest that FFRCT accurately predicts the hemodynamic significance of coronary lesions when compared to directly-measured FFR during invasive cardiac catheterization (Koo 2011).

Conditions

Interventions

TypeNameDescription
PROCEDUREICA (Invasive Coronary Angiography)Per the protocol, patients will have an Invasive Coronary Angiography.
PROCEDUREFFR (Fractional Flow Reserve)Per the protocol, patients will have a Fractional Flow Reserve procedure.
PROCEDUREcCTA (coronary computed tomography angiography)Per the protocol, patients will have a coronary computed tomography angiography.
OTHERFFRct Analysis (Fractional Flow Reserve Computed Tomography)Per the protocol, patients will have a fractional flow reserve computed tomography.

Timeline

Start date
2012-09-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2012-12-31
Last updated
2017-11-14
Results posted
2017-11-14

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01757678. Inclusion in this directory is not an endorsement.